Steven Fruchtman is the founder of Onconova Therapeutics. Latest round: Growth. Backed by OrbiMed, Torrey Pines. Based in New York, Country (or null).
Steven Fruchtman was the President and Chief Executive Officer of Onconova Therapeutics. Onconova Therapeutics merged with Trawsfynydd Therapeutics to form Traws Pharma, Inc., a virology and oncology company. Fruchtman became the President and CSO, Oncology of the combined company. The company focuses on developing best-in-class medicines.
Full founder directory · Investor directory · Company funding database · Fundraising library